secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zivo Bioscience, Inc. (ZIVO)
CIK:        0001101026
Form:       8-K
Filed at:   2025-12-23T23:59:59+00:00
Accession:  0001654954-25-014296
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CFO Keith Marchiando resigns; William Sullivan appointed Interim CFO
--------------------------------------------------------------------

- Keith Marchiando resigns as CFO effective Dec 31, 2025; receives $27,040/mo through Dec 31, 2026.
- Marchiando retains option for 150,000 shares at $7.96, exercisable until June 30, 2027; all other options cancelled.
- William A. Sullivan appointed Interim CFO effective Dec 19, 2025 as independent contractor at $285/hour.
- Sullivan's contract is initially 60 days, auto-renewing monthly; no other compensation or equity.
- Marchiando's separation includes confidentiality and non-disparagement obligations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425014296/0001654954-25-014296-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1101026/000165495425014296/zivo_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-25-014296

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer